Buchang Pharma's controlling shareholder pledges more shares

Shandong Buchang Pharmaceuticals Co., Ltd. announced on November 10, 2025, that its controlling shareholder, Buchang (Hong Kong) Holding Company Limited, pledged an additional 11 million shares. This latest pledge, made to China Everbright Bank Company Limited Jinan Branch for operational needs, brings Buchang (Hong Kong)'s total pledged shares to 100.93 million, representing 20.56% of its holdings and 9.57% of the company's total share capital.

Before this transaction, Buchang (Hong Kong) held 490.96 million shares, accounting for 46.56% of the company's total share capital, with 89.93 million shares already pledged. Including its concerted parties, the total shares held by the controlling shareholder group amount to 598.2 million shares, or 56.72% of the company's total share capital. The total pledged shares for this group now stand at 100.93 million shares, representing 16.87% of their combined holdings and 9.57% of the company's total share capital.

The company stated that Buchang (Hong Kong) possesses sufficient risk control capabilities and repayment capacity. The pledge risk is deemed controllable, with no current risk of forced liquidation. The company also confirmed that this pledge will not lead to a change in actual control or impact the company's production, operations, or corporate governance.